Quantitative Evaluation of Compliance with Recommendation for Sulfonylurea Dose Co-Administered with DPP-4 Inhibitors in Japan

After the launch of dipeptidyl peptidase-4 (DPP-4), a new oral hypoglycemic drug (OHD), in December 2009, severe hypoglycemia cases were reported in Japan. Although the definite cause was unknown, co-administration with sulfonylureas (SU) was suspected as one of the potential risk factors. The Japan...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Tomomi, Shiosakai, Kazuhito, Takeda, Yasuaki, Takahashi, Shinji, Kobayashi, Masahiko, Sakaguchi, Motonobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834918/
https://www.ncbi.nlm.nih.gov/pubmed/24300302
http://dx.doi.org/10.3390/pharmaceutics4030479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834918/
https://www.ncbi.nlm.nih.gov/pubmed/24300302
http://dx.doi.org/10.3390/pharmaceutics4030479

Ejemplares similares